Progressive ataxia in a natalizumab‐treated multiple sclerosis patient: the dark side of JC virus infection

Table S1. Alignment of DNA and amino acid sequences of VP1 C terminus from JCV strains identified from different JCV-GCN cases. Table S2. Clinical, CSF and MRI features of patients with natalizumab-associated JCV granule cell neuronopathy. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.